Drug intelligence / Profile preview

polyethylene glycol 3350 and electrolytes (Braintree Laboratories)

Development stage
Unknown
Lead developer
Braintree
Modality
Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol 3350 and electrolytes (PEG 3350 and electrolytes) is an osmotic laxative and bowel-cleansing preparation. It is formulated as a powder for oral solution or as a pre-mixed oral solution, containing polyethylene glycol 3350 as the active osmotic agent combined with essential electrolytes (such as sodium sulfate, sodium bicarbonate, sodium chloride, and potassium chloride) to maintain fluid and electrolyte balance during bowel evacuation. PEG 3350 works by retaining water in the intestinal lumen through osmotic action, which softens the stool, increases stool volume, and promotes peristalsis. This combination is widely indicated for whole bowel irrigation in preparation for colonoscopy or other gastrointestinal procedures, as well as for the treatment of chronic constipation and fecal impaction, particularly in pediatric populations. Key developers of formulations of this drug include Sunflower Pharmaceutical Group and Guangzhou Kanghe Pharmaceutical.

Brand names
Clenz-LyteColyteGaviLyteGaviLyte-CGaviLyte-GGaviLyte-NGoLYTELYMovicolMoviPrepNulytelyPeg-lytePlenvuTrilyte舒斯通小葵花
Other names
PEG 3350 and electrolytesPEG3350 and electrolytesPEG-3350 and electrolytesPEG 3350 electrolyte powderPEG3350 electrolyte powderPEG-3350 electrolyte powderPEG 3350 with electrolytesPEG3350 with electrolytesPEG-3350 with electrolytesmacrogol 3350 and electrolytesmacrogol3350 and electrolytesmacrogol-3350 and electrolytesmacrogol 3350 with electrolytesmacrogol3350 with electrolytesmacrogol-3350 with electrolytespolyethylene glycol 3350 and electrolytes for oral solutionpolyethylene glycol 3350 and electrolytes oral solutionpolyethylene glycol 3350 with electrolytes复方聚乙二醇(3350)电解质口服溶液复方聚乙二醇(3350)电解质散

Beyond the preview

Go deeper on polyethylene glycol 3350 and electrolytes (Braintree Laboratories).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 3350 and electrolytes (Braintree Laboratories).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call